Filtered By:
Condition: Alcoholism
Management: Marketing
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Bristol-Myers Squibb Signs Exclusive Worldwide License Agreement with Nitto Denko for Targeted siRNA Therapy in Advanced Non-alcoholic Steatohepatitis (NASH) and Cirrhosis Due to NASH
NEW YORK & OSAKA, Japan--(Healthcare Sales & Marketing Network)--Bristol-Myers Squibb Company (BMY) and Nitto Denko Corporation (Nitto) (6988:Tokyo) today announced the companies have entered into an agreement granting Bristol-Myers Squibb exclusive worldw... Biopharmaceuticals, Licensing Bristol-Myers Squibb, Nitto Denko
Source: HSMN NewsFeed - November 10, 2016 Category: Pharmaceuticals Source Type: news
